Angioedema Newswire

Angioedema Newswire

Comprehensive Real-Time News Feed for Angioedema.

Results 1 - 5 of 5 in Angioedema

  1. Stock Plunges as Biocryst's Angioedema Drug Flunks Phase II StudyRead the original story

    Yesterday | BioSpace

    BioCryst Pharmaceuticals, Inc. , today announced results from OPuS-2 , a clinical trial of avoralstat administered three times daily as a liquid-filled soft gel formulation for the prophylactic treatment of hereditary angioedema attacks. In the OPuS-2 study, HAE patients with a historical attack frequency of greater than 0.45 attacks per week were randomized to treatment with either 500 mg or 300 mg of avoralstat, or placebo, administered three times daily for 12 weeks.

    Comment?

  2. Dyax shares jump as antitrust waiting period for Shire acquisition endsRead the original story w/Photo

    Dec 2, 2015 | MarketWatch

    ... is offering $37.30 a share for Dyax, along with another $4 a share with the approval of Dyax's DX-2930 hereditary angioedema treatment.

    Comment?

  3. Hamilton man with rare blood disorder 'very happy' drug to be fundedRead the original story w/Photo

    Sep 16, 2015 | Waikato Times

    Shane Burke is relieved his Kiwi family will get access to a life-saving drug for the rare hereditary disorder they share with him. The Hamiltonian was diagnosed with the rare blood disorder hereditary angioedema at age 17. It causes sudden swelling of body parts including the throat and can be life threatening.

    Comment?

  4. FDA approves new drug to treat heart failureRead the original story w/Photo

    Jul 8, 2015 | Science Blog

    ... (hypotension), high blood potassium levels (hyperkalemia), and poor function of the kidneys (renal impairment). Angioedema (an allergic reaction usually appearing as swelling of the lips or face) was also reported with Entresto; black patients and ...

    Comment?

  5. FDA approves new drug to treat heart failureRead the original story

    Jul 8, 2015 | Medical News Today

    ... (hypotension), high blood potassium levels (hyperkalemia), and poor function of the kidneys (renal impairment). Angioedema (an allergic reaction usually appearing as swelling of the lips or face) was also reported with Entresto; black patients and ...

    Comment?